Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.

Cristina Papayannidis Chiara SartorAlida DominiettoElisabetta ZapponeMario ArpinatiGiovanni MarconiGianluca CristianoJacopo NanniSarah ParisiFrancesco BarbatoStefania PaoliniSimona SoveriniCarolina TerragnaValentina RobustelliNicoletta TestoniGabriella ChirumboloAntonio CurtiMichele CavoFrancesca Bonifazi

Published in: Hematological oncology (2021)

Keyphrases

acute lymphoblastic leukemia
stem cells
stem cell transplantation
bone marrow
allogeneic hematopoietic stem cell transplantation
low dose
hematopoietic stem cell
peripheral blood
high dose
cell therapy
acute myeloid leukemia
hodgkin lymphoma